Sara L. Van Driest
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 31
-
- Cardiomyopathy and Myosin Studies 14
- Developmental Neuroscience top 5%
-
- Pharmaceutical studies and practices 24
- Pharmacological Effects and Toxicity Studies 6
- Nephrology top 5%
- Acute Kidney Injury Research 6
-
- Statistical Methods in Clinical Trials 7
-
- Genetic Associations and Epidemiology 7
- Genomics and Rare Diseases 6
- Co-authors
- Michael J. AckermanSteve R. OmmenBernard J. GershA. Jamil TajikDan M. RodenMelissa L. WillJosh F. PetersonJoshua C. Denny
- Journals
- Clinical Pharmacology & Therapeutics (14 papers)Clinical and Translational Science (8 papers)Journal of the American College of Cardiology (7 papers)
- Partner nations
- United StatesDenmarkGermany
In The Last Decade
Sara L. Van Driest
100 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Pharmacology 638
- Cardiology and Cardiovascular Medicine 1.5k
- Developmental Neuroscience 152
- Pediatrics, Perinatology and Child Health 462
- Nephrology 148
Countries citing papers authored by Sara L. Van Driest
This map shows the geographic impact of Sara L. Van Driest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara L. Van Driest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara L. Van Driest more than expected).
Fields of papers citing papers by Sara L. Van Driest
This network shows the impact of papers produced by Sara L. Van Driest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara L. Van Driest. The network helps show where Sara L. Van Driest may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sara L. Van Driest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 7 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 16 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 10 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 40 | |
| 12 | 2018 | 6 | |
| 13 | 2014 | 42 | |
| 14 | 2013 | 20 | |
| 15 | 2012 | 30 | |
| 16 | 2005 | 72 | |
| 17 | 2005 | 0 | |
| 18 | 2004 | 1 | |
| 19 | 2004 | 1 | |
| 20 | 2004 | 326 |
About Sara L. Van Driest
Sara L. Van Driest is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Developmental Neuroscience, having authored 106 papers that have together received 3.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (31 papers), Pharmaceutical studies and practices (24 papers), Cardiomyopathy and Myosin Studies (14 papers), Statistical Methods in Clinical Trials (7 papers), Genetic Associations and Epidemiology (7 papers), Genomics and Rare Diseases (6 papers), Acute Kidney Injury Research (6 papers) and Pharmacological Effects and Toxicity Studies (6 papers). The work is most often cited by research in Pharmacology (638 citations), Cardiology and Cardiovascular Medicine (1.5k citations) and Developmental Neuroscience (152 citations). Sara L. Van Driest has collaborated with scholars based in United States, Denmark and Germany. Frequent co-authors include Michael J. Ackerman, Steve R. Ommen, Bernard J. Gersh, A. Jamil Tajik, Dan M. Roden, Melissa L. Will, Josh F. Peterson, Joshua C. Denny, Vlad C. Vasile and Rick A. Nishimura. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Clinical and Translational Science, Journal of the American College of Cardiology, Pediatric Research and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.